Five Research Articles That Transformed Addiction Medicine Practices
Episode Overview
Smoking cessation can significantly extend survival even after a lung cancer diagnosis. Targeted oral naltrexone reduces binge drinking in sexual and gender minority men. Buprenorphine-naloxone is effective and safe for treating opioid use disorder in pregnancy. No amount of alcohol is beneficial for cardiovascular health. Patient-centred measures of success are crucial in opioid use disorder treatment.
Even quitting smoking at this point could extend survival.
In this episode of the Addiction Medicine Journal Club, Dr. John Keenan and Dr. Sonia Del Tredici dive into five pivotal research articles that have significantly influenced their addiction medicine practices. With a blend of humour and vulnerability, they share personal anecdotes about past missteps and how new research has guided them to better treatment strategies.
From the benefits of smoking cessation post-lung cancer diagnosis to the effectiveness of targeted oral naltrexone for alcohol use disorder among sexual and gender minority men, the discussion is rich with practical insights. They also explore the impact of buprenorphine-naloxone in pregnancy, debunk the myth of red wine being good for the heart, and highlight patient-centred measures of success in opioid use disorder treatment.
This episode is a goldmine for anyone looking to stay current with addiction medicine research and improve their clinical practice. Don’t miss out on these valuable lessons and real-world applications that could transform how you approach patient care.